Ocean Biomedical, Inc.

OCEA

Pharmaceutical Preparations·NEW YORK, NY

Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.

All Filings(255 total)

TypeDateAccessionPeriodSize

NT 10-Q

Aug 14, 2025

0001641172-25-023734NT 10-Q

Jun 30, 2025

39.4 KB

25-NSE

Aug 8, 2025

0001354457-25-000798

—

4.3 KB

8-K

Aug 5, 2025

0001641172-25-0222718-K

Jul 31, 2025

248.4 KB

8-K

Jul 23, 2025

0001641172-25-0207308-K

Jul 17, 2025

187.4 KB

8-K

Jul 16, 2025

0001641172-25-0199248-K

Jul 10, 2025

245.4 KB

8-K

Jun 13, 2025

0001641172-25-0151298-K

Jun 12, 2025

197.3 KB

10-Q

May 15, 2025

0001641172-25-01108010-Q

Mar 31, 2025

6.1 MB

10-K/A

Apr 29, 2025

0001641172-25-006669ANNUAL REPORT

Dec 31, 2024

532.1 KB

8-K

Apr 23, 2025

0001641172-25-005788

Apr 22, 2025

228.9 KB

10-K

Apr 8, 2025

0001641172-25-003155

Dec 31, 2024

11.7 MB

8-K

Apr 1, 2025

0001641172-25-002074

Mar 28, 2025

275.0 KB

NT 10-K

Apr 1, 2025

0001641172-25-002034

Dec 31, 2024

34.6 KB

8-K

Mar 26, 2025

0001641172-25-000747

Mar 26, 2025

252.1 KB

8-K

Mar 20, 2025

0001493152-25-011046

Mar 14, 2025

254.2 KB

DEFA14A

Mar 10, 2025

0001493152-25-009713

—

28.6 KB

8-K

Mar 10, 2025

0001493152-25-009707

Mar 4, 2025

258.8 KB

8-K

Feb 26, 2025

0001493152-25-008395

Feb 20, 2025

28.3 MB

DEF 14A

Feb 26, 2025

0001493152-25-008279

Feb 26, 2025

671.7 KB

8-K

Feb 21, 2025

0001493152-25-007933

Feb 21, 2025

253.7 KB

PRE 14A

Feb 14, 2025

0001493152-25-006994

Feb 14, 2025

670.2 KB

SCHEDULE 13G/A

Feb 13, 2025

0001493152-25-006338

—

11.8 KB

8-K

Feb 12, 2025

0001493152-25-006180

Feb 11, 2025

254.5 KB

8-K

Jan 15, 2025

0001493152-25-002237

Jan 7, 2025

260.6 KB

10-Q

Jan 13, 2025

0001493152-25-001880

Sep 30, 2024

7.7 MB

10-Q

Dec 23, 2024

0001493152-24-051208

Jun 30, 2024

10.9 MB

25 filings shown